title: Alpha 1 antichymotrypsin is aberrantly expressed during melanoma progression and predicts poor survival for patients with metastatic melanoma.
authors.forename: Yang
authors.initials: Y
authors.lastname: Wang
authors.forename: Helen
authors.initials: H
authors.lastname: Jiang
authors.forename: Derek
authors.initials: D
authors.lastname: Dai
authors.forename: Mingwan
authors.initials: M
authors.lastname: Su
authors.forename: Magdalene
authors.initials: M
authors.lastname: Martinka
authors.forename: Penny
authors.initials: P
authors.lastname: Brasher
authors.forename: Yaohua
authors.initials: Y
authors.lastname: Zhang
authors.forename: David
authors.initials: D
authors.lastname: McLean
authors.forename: Junling
authors.initials: J
authors.lastname: Zhang
authors.forename: Wency
authors.initials: W
authors.lastname: Ip
authors.forename: Gang
authors.initials: G
authors.lastname: Li
authors.forename: Xuejun
authors.initials: X
authors.lastname: Zhang
authors.forename: Youwen
authors.initials: Y
authors.lastname: Zhou
mesh_terms: D014408:Biomarkers, Tumor / Q000096:biosynthesis* / Q000378:metabolism; D018450:Disease Progression; D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics*; D006801:Humans; D008545:Melanoma / Q000175:diagnosis* / Q000378:metabolism* / Q000473:pathology; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D011379:Prognosis; D016019:Survival Analysis; D000514:alpha 1-Antichymotrypsin / Q000096:biosynthesis* / Q000378:metabolism
chemical_list: D014408:Biomarkers, Tumor; D000514:alpha 1-Antichymotrypsin